December 17, 2013

Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

Key Points

Key points are not available for this paper at this time.

Abstract

Autologous T cells directed to the LMP2 or LMP1 and LMP2 antigens can induce durable complete responses without significant toxicity. Their earlier use in the disease course may reduce delayed treatment-related mortality.

Bookmark

Cite This Study

Bollard et al. (Tue,) studied this question.

synapsesocial.com/papers/69da461b0f778bd2e4684a46 https://doi.org/https://doi.org/10.1200/jco.2013.51.5304

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer2007 · 276 citations
2Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma.2003 · 259 citations
3Administration of Neomycin Resistance Gene Marked EBV Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Hodgkin Disease. Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas1998 · 25 citations
4Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state1994 · 492 citations
5Immunologic and Clinical Responses after Vaccinations with Peptide-Pulsed Dendritic Cells in Metastatic Renal Cancer Patients2006 · 227 citations

Bookmark